Md. Badirujjaman

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Indian Institute of Technology Guwahati(Current)

Md. Badirujjaman is an author at Indian Institute of Technology Guwahati specializing in anticancer prodrug design, prodrug design, and medicinal chemistry.

ORCID

Publications per year

2023–2023

Publications

Cysteine-responsive prodrug of the anti-cancer drug amonafide: fluorogenic adjuvant drug delivery with hydrogen sulfide (H<sub>2</sub>S)

Sulendar K. Mahato, Pallavi Barman, Md. Badirujjaman et al. · Chemical Communications · 2023 · 17 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +12

Dual‐Stimuli‐Activatable Hybrid Prodrug for the Self‐Immolative Delivery of an Anticancer Agent and Hydrogen Sulfide with Turn‐On Fluorescence

Md. Badirujjaman, Pallavi Barman, Krishna P. Bhabak · Chemistry - A European Journal · 2023 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–2 of 2